North America and Europe Artificial Pancreas Systems Market Expected to be worth US$ 250 Mn by 2026 End
Diabetes Type 1 segment is likely to prevail over Diabetes Type 2 segment in the North America and Europe artificial pancreas systems market The Diabetes Type 1 segment was estimated to account for a little…